Search in:

Advanced search

Leukemia & Lymphoma Volume 57, 2016 - Issue 3

Submit an article Journal homepage

165

Views

CrossRef citations to date

Altmetric

Commentaries

Whole blood EBV-DNA: A surrogate for immune dysfunction in aggressive lymphoma?

Qingyan CuiUniversity of Queensland Diamantina Institute, Translational Research Institute, University of Queensland, Australia and Correspondence[email protected]

Maher K. GandhiUniversity of Queensland Diamantina Institute, Translational Research Institute, University of Queensland, Australia and ;Princess Alexandra Hospital, Brisbane, Queensland, Australia

Pages 507-508 | Received 17 Aug 2015, Accepted 23 Aug 2015, Published online: 08 Oct 2015

Cite this article
https://doi.org/10.3109/10428194.2015.1087522
CrossMark

Full Article
Figures & data
References
Supplemental
Citations
Metrics
Reprints & Permissions

References

Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004;4:757–768.
PubMed Web of Science ®Google Scholar
Gandhi MK, Tellam JT, Khanna R. Epstein-Barr virus-associated Hodgkin's lymphoma. Br J Haematol 2004;125:267–281.
PubMed Web of Science ®Google Scholar
Nourse JP, Jones K, Gandhi MK. Epstein-Barr Virus-related post-transplant lymphoproliferative disorders: pathogenetic insights for targeted therapy. Am J Transplant 2011;11:888–895.
PubMed Web of Science ®Google Scholar
Evens AM, Choquet S, Kroll-Desrosiers AR, et al. Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern era. Am J Transplant 2013;13:1512–1522.
PubMed Web of Science ®Google Scholar
Gallagher A, Armstrong AA, MacKenzie J, et al. Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin's disease. Int J Cancer 1999;84:442–448.
PubMed Web of Science ®Google Scholar
Au WY, Pang A, Choy C, et al. Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients. Blood 2004;104:243–249.
PubMed Web of Science ®Google Scholar
Gandhi MK, Lambley E, Burrows J, et al. Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma. Clin Cancer Res 2006;12:460–464.
PubMed Web of Science ®Google Scholar
Hohaus S, Santangelo R, Giachelia M, et al. The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma. Clin Cancer Res 2011;17:2885–2892.
PubMed Web of Science ®Google Scholar
Gandhi MK. Epstein-Barr virus-associated lymphomas. Expert Rev Anti Infect Ther 2006;4:77–89.
PubMedGoogle Scholar
Tisi MC, Cupelli E, Santangelo R, et al. Whole Blood EBV-DNA predicts outcome in diffuse large B cell lymphoma. Leuk Lymphoma 2016;57:628–634.
PubMed Web of Science ®Google Scholar
Aw D, Silva AB, Palmer DB. Immunosenescence: emerging challenges for an ageing population. Immunology 2007;120:435–446.
PubMed Web of Science ®Google Scholar
Diepstra A, van Imhoff GW, Schaapveld M, et al. Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients. J Clin Oncol 2009;27:3815–3821.
PubMed Web of Science ®Google Scholar
Cardenas D, Velez G, Orfao A, et al. EBV-specific CD8+ T lymphocytes from diffuse large B cell lymphoma patients are functionally impaired. Clin Exp Immunol 2015;182:173–183.
PubMed Web of Science ®Google Scholar
Nicolae A, Pittaluga S, Abdullah S, et al. EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment. Blood 2015;126:863–872.
PubMed Web of Science ®Google Scholar
Lu TX, Liang JH, Miao Y, et al. Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age. Sci Rep 2015;5:12168.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Whole blood EBV-DNA: A surrogate for immune dysfunction in aggressive lymphoma?

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Whole blood EBV-DNA: A surrogate for immune dysfunction in aggressive lymphoma?

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date